New Zealand researchers published today an article in the British Journal of Psychiatry a paper that outlines their investigation into the efficacy and safety of Micronutrients in the treatment of ADHD in adults.
The researchers assigned 80 adults with ADHD into two groups: half of them used Micronutrients, and the other half used a placebo.
After the 8-week trial, significant differences emerged between the two groups on self- and observer-ADHD rating scales. Clinicians rated those in the Micronutrients group has having improved more—not only in ADHD symptoms, but generally, too—than the placebo group.
In addition, it seemed those with moderate or severe depression saw a greater change in mood if they were taking Micronutrients than if they were taking the placebo.
This is great news. Our critics have been demanding these types of trials, and they validate the more than 25 studies that have been published to date. Expect more research like this in the coming months.
Go to Q96health.com for more information